S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
S&P 500   2,594.17 (-99.21%)
DOW   22,021.77 (+1.78%)
QQQ   190.00 (+2.54%)
AAPL   251.94 (+1.70%)
FB   162.15 (+3.42%)
MSFT   158.29 (+5.74%)
GOOGL   1,136.79 (+2.39%)
AMZN   1,957.01 (+3.00%)
CGC   14.44 (-1.03%)
NVDA   261.28 (+3.39%)
BABA   189.06 (+0.25%)
MU   44.65 (+2.69%)
GE   7.82 (+2.63%)
TSLA   513.01 (-0.99%)
AMD   47.88 (+2.79%)
T   29.68 (-0.54%)
F   5.01 (-3.47%)
NFLX   370.31 (+3.69%)
BAC   22.26 (+3.06%)
GILD   75.10 (+3.09%)
DIS   96.94 (+0.56%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Crispr TherapeuticsHalozyme TherapeuticsAllogene TherapeuticsMomenta PharmaceuticalsAudentes Therapeutics
SymbolNASDAQ:CRSPNASDAQ:HALONASDAQ:ALLONASDAQ:MNTANASDAQ:BOLD
Price Information
Current Price$43.12$18.03$20.19$28.13$59.97
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$74.42$25.33$33.11$37.25$50.75
% Upside from Price Target72.62% upside40.51% upside64.00% upside32.42% upside-15.37% downside
Trade Information
Market Cap$2.54 billion$2.42 billion$2.49 billion$3.22 billion$2.77 billion
Beta2.721.930.531.762.18
Average Volume993,9062,281,639824,3601,372,5291,504,389
Sales & Book Value
Annual Revenue$289.59 million$195.99 millionN/A$23.87 millionN/A
Price / Sales9.0612.70N/A138.21N/A
Cashflow$1.34 per shareN/AN/AN/AN/A
Price / Cash32.24N/AN/AN/AN/A
Book Value$17.02 per share$0.63 per share$5.16 per share$4.59 per share($7.48) per share
Price / Book2.5328.62N/A6.13N/A
Profitability
Net Income$66.86 million$-72,240,000.00$-184,590,000.00$-290,050,000.00$-128,820,000.00
EPS$1.17($0.50)($1.83)($3.03)($3.40)
Trailing P/E Ratio44.45N/AN/AN/AN/A
Forward P/E RatioN/A12.70N/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins23.09%-36.86%N/A-1,215.25%N/A
Return on Equity (ROE)11.74%-33.71%-28.56%-82.12%N/A
Return on Assets (ROA)9.62%-16.20%-25.49%-58.59%-38.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A4.17%0.08%N/AN/A
Current Ratio17.29%6.35%16.46%5.08%12.80%
Quick Ratio17.29%6.00%16.46%5.08%12.79%
Ownership Information
Institutional Ownership Percentage52.02%91.73%57.34%97.03%96.33%
Insider Ownership Percentage21.40%2.60%36.50%3.40%5.30%
Miscellaneous
Employees188281122131207
Shares Outstanding60.85 million138.07 million124.91 million117.28 million46.27 million
Next Earnings Date5/4/2020 (Estimated)5/5/2020 (Estimated)5/5/2020 (Estimated)5/7/2020 (Estimated)N/A
OptionableOptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel